UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000008551
Receipt No. R000010051
Official scientific title of the study A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnaires
Date of disclosure of the study information 2012/07/30
Last modified on 2016/07/30 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A study on relapse of the symptom comparing 2 weeks and 8 weeks of treatment period in GERD patients using the newly established GerdQ questionnaires
Title of the study (Brief title) GERD treatment period study
Region
Japan

Condition
Condition GERD
Classification by specialty
Gastroenterology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare the relapse of GER symptoms in relation with the length of the treatment in the patients with reflux esophagitis.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes length of the GER symptom free periods after the treatment
Key secondary outcomes 1) factors affecting the relapse of GERD
2) difference of GER symptoms between before and after the 2 week treatment and the rates of the disappearance of GER symptoms
3) the severity of GER symptoms in case of the relapse

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification NO
Dynamic allocation NO
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 no additional treatment
Interventions/Control_2 Additional treatment of esomeprazole for 6 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria LA grade A or B diagnosed by esophagoscopy within 6 months
Having GER symptoms
Disappearance of GER symptoms after the treatment by esomeprazole (20 mg/day for 2 weeks) by GerdQ questionnaire
Key exclusion criteria Patiets with the history of gastric surgeries
Patients with alarm symptoms such as vomiting, GI bleeding, rapid body weight loss
Patients of alcohol or drug dependence
Patients with severe endocrine problems
Patients with severe injuries of heart, liver, kidney or bone marrow functions
Patients with allergy against the test drugs
Patients with pregnancy, possible pregnancy or breast feeding, or hope of pregnancy during the test period
Patients whom the doctor decide as not proper for the study
Target sample size 80

Research contact person
Name of lead principal investigator Masashi Matsushima
Organization Tokai University Tokyo Hospital
Division name Internal Medicine (Gastroenterology)
Address 1-2-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan
TEL 03-3370-2321
Email

Public contact
Name of contact person Masashi Matsushima
Organization Tokai University Tokyo Hospital
Division name Internal Medicine (Gastroenterology)
Address 1-2-5 Yoyogi, Shibuya-ku, Tokyo 151-0053, Japan
TEL 03-3370-2321
Homepage URL
Email

Sponsor
Institute Tokai University School of Medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Showa University Hospital
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東海大学東京病院(東京都) Tokai University Tokyo Hospital
東海大学医学部付属病院(神奈川県) Tokai University Hospital
昭和大学病院(東京都)Showa University Hospital

Other administrative information
Date of disclosure of the study information
2012 Year 07 Month 30 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2012 Year 06 Month 11 Day
Anticipated trial start date
2012 Year 07 Month 30 Day
Last follow-up date
2014 Year 03 Month 31 Day
Date of closure to data entry
2014 Year 06 Month 30 Day
Date trial data considered complete
2014 Year 06 Month 30 Day
Date analysis concluded
2014 Year 06 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 07 Month 27 Day
Last modified on
2016 Year 07 Month 30 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010051